Sepsis Criteria and Revision in Toxicological Intensive Care Unit Sepsis criteria in toxicological ICU
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 10 No. 4 (2020),
16 November 2020
,
Page 31452
https://doi.org/10.32598/ijmtfm.v10i4.31452
Abstract
Background: Sepsis is one of the significant causes of mortality in hospitalized patients. This cross-sectional study was performed to determine the frequency of positive blood culture and assess sepsis criteria based on Third International Consensus Definitions (related to Sequential Organ Failure Assessment score) and clinical and paraclinical findings (i.e., on-admission leukocytosis, increased lactate level, and fever) in poisoned patients admitted to the Toxicological Intensive Care Unit (TICU).
Methods: Medical records of a total of 2000 poisoned patients admitted to the TICU of Loghman Hakim Hospital from 2016 to 2018 were assessed. Among them, 189 cases (9.45%) with suspected sepsis were considered eligible to be enrolled in the study.
Results: Of 189 cases, 146 (77.24%) had possible signs and symptoms of sepsis as well as SOFA score higher than two with positive blood culture in 81 cases (55%). The Mean±SD serum level of lactate was 25.97±16.32 on admission. The most common pathogen detected in blood culture was coagulase-negative Staphylococci in 35 (24.0%) out of 146 cases. Glasgow Coma Scale (GCS) less than 12, age older than 50 years, and bilirubin more than 1.2 mg/dL were found as independent predictors of sepsis on multivariate analysis.
Conclusion: Based on our findings, it is proposed that the sepsis definition should not be restricted to the guidelines. The patients’ poisoning background and presence of many confounding factors, including poisoning-induced on-admission increased lactate levels, leukocytosis, and disturbed arterial blood gas provide a critical decision-making situation to confirm sepsis according to guidelines.
- Blood culture
- Intensive care unit
- Lactate
- Sepsis
- Toxicity
How to Cite
References
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The 3rd international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315(8):801-10. [DOI:10.1001/jama.2016.0287] [PMID] [PMCID]
Esposito S, De Simone G, Boccia G, De Caro F, Pagliano P. Sepsis and septic shock: New definitions, new diagnostic and therapeutic approaches. J Glob Antimicrob Resist. 2017; 10:204-12. [DOI:10.1016/j.jgar.2017.06.013] [PMID]
Kochanek KD, Murphy SL, Xu J, Tejada-Vera B. Deaths: Final data for 2014. Natl Vital Stat Rep. 2016; 65(4):1-122. [PMID]
World Health Organization. Sepsis [Internet]. 2018 [Updated 2020 August 26]. Available from: https://www.who.int/news-room/fact-sheets/detail/sepsis
Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013; 369(9):840-51. [DOI:10.1056/NEJMra1208623] [PMID]
Annane D, Aegerter P, Jars-Guincestre MC, Guidet B, CUB-Réa Network. Current epidemiology of septic shock: The CUB-Réa Network. Am J Respir Crit Care Med. 2003; 168(2):165-72. [DOI:10.1164/rccm.2201087] [PMID]
Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 34(6):1589-96. [DOI:10.1097/01.CCM.0000217961.75225.E9] [PMID]
Rodríguez-Baño J. Treatment of sepsis-related organ dysfunction. JAMA. 2012; 308(12):1205-6. [DOI:10.1001/2012.jama.11262] [PMID]
Brunkhorst FM, Oppert M, Marx G, Bloos F, Ludewig K, Putensen C, et al. Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: A randomized trial. JAMA. 2012; 307(22):2390-9.[DOI:10.1001/jama.2012.5833] [PMID]
Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: Systematic review and meta-analysis of randomised trials. BMJ. 2004; 328(7441):668. [DOI:10.1136/bmj.38028.520995.63] [PMID] [PMCID]
Harbarth S, Nobre V, Pittet D. Does antibiotic selection impact patient outcome? Clin Infect Dis. 2007; 44(1):87-93. [DOI:10.1086/510075] [PMID]
Morgenthaler NG, Kostrzewa M. Rapid identification of pathogens in positive blood culture of patients with sepsis: Review and meta-analysis of the performance of the sepsityper kit. Int J Microbiol. 2015; 2015:827416. [DOI:10.1155/2015/827416] [PMID] [PMCID]
Leggieri N, Rida A, François P, Schrenzel J. Molecular diagnosis of bloodstream infections: Planning to (physically) reach the bedside. Curr Opin Infect Dis. 2010; 23(4):311-9.[DOI:10.1097/QCO.0b013e32833bfc44] [PMID]
Kamalbeik S, Talaie H, Mahdavinejad A, Karimi A, Salimi A. Multidrug-resistant Acinetobacter baumannii infection in intensive care unit patients in a hospital with building construction: is there an association? Korean J Anesthesiol. 2014; 66(4):295-9. [DOI:10.4097/kjae.2014.66.4.295] [PMID] [PMCID]
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign guidelines committee including the pediatric subgroup. surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013; 39(2):165-228. [DOI:10.1007/s00134-012-2769-8] [PMID] [PMCID]
Phua J, Ngerng W, See K, Tay C, Kiong T, Lim H, et al. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care. 2013; 17(5):R202. [DOI:10.1186/cc12896] [PMID] [PMCID]
Talaie H, Sabeti S, Mahdavinejad A. A survey on microorganisms and their sensitivity by E-Test in ventilator -associated pneumonia at Toxicological-Intensive Care Unit of Loghman-Hakim Hospital. Acta Biomed 2010; 81(3):210-6. https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/798
Talaie H, Jabari HR, Shadnia S, Pajouhmand A, Nava-Ocampo AA, Youssefi M. Cefepime/clindamycin vs. ceftriaxone/clindamycin for the empiric treatment of poisoned patients with aspiration pneumonia. Acta Biomed. 2008; 79(2):117-22. [PMID]
Farnaghi F, Talaie H, Pournasiri Z, Sadeghi R, Owliaey H, Hassanian-Moghaddam H, et al. Effect of aluminium phosphide poisoning on blood cortisol level. Iran J Toxicol. 2013; 6(19):746-50. http://ijt.arakmu.ac.ir/article-1-174-en.html
Mozafari N, Mortazavi HS, Alinia T, Barari B, Talaie H. Is serum lactate level as a prognostic factor in ventilator associated pneumonia incidence and death among ICU poisoned patients? Iran Red Crescent Med J. 2017; 19(1):e43951. [DOI:10.5812/ircmj.43951]
Talaie H, Owliaey H, Pajoumand A, Gholaminejad M, Mehrpour O. Temperature changes among organophosphate poisoned patients, Tehran-Iran. Daru. 2012; 20(1):52.[DOI:10.1186/2008-2231-20-52] [PMID] [PMCID]
Napolitano LM. Sepsis 2018: Definitions and guideline changes. Surg Infect. 2018; 19(2):117-25. [DOI:10.1089/sur.2017.278] [PMID]
Cheng B, Xie G, Yao S, Wu X, Guo Q, Gu M, et al. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit Care Med. 2007; 35(11):2538-46. [DOI:10.1097/01.CCM.0000284492.30800.00] [PMID]
Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med. 2004; 30(4):589-96. [DOI:10.1007/s00134-004-2157-0] [PMID]
Blanco J, Muriel-Bombín A, Sagredo V, Taboada F, Gandía F, Tamayo L, et al. Grupo de estudios y análisis en cuidados intensivos. incidence, organ dysfunction and mortality in severe sepsis: A Spanish multicentre study. Crit Care. 2008; 12(6):R158. [DOI:10.1186/cc7157] [PMID] [PMCID]
Zhou J, Qian C, Zhao M, Yu X, Kang Y, Ma X, et al. China critical care clinical trials group. epidemiology and outcome of severe sepsis and septic shock in intensive care units in mainland China. PLoS One. 2014; 9(9):e107181. [DOI:10.1371/journal.pone.0107181] [PMID] [PMCID]
Kouchek M, Asghari R, Mahdavinejad A, Salimi A, Barari B, Seyedrazi P, et al. Comparative study between teicoplanin and vancomycin in Methicillin-Resistant Staphylococcus Aureus (MRSA) infectious of Toxicological Intensive Care Unit (TICU) patients-Tehran-Iran. Life Sci. 2014; 11(Suppl. 3):83-90. http://www.lifesciencesite.com/lsj/life1103s/013_22641life1103s14_83_90.pdf
Talaie H, Kamalbeik S, Haji Seyed Razi P, Barari B, Rezaie Hemami M, Zamani N, Mahdavinejad A. VAP or poisning; which one has more effect on patient’s outcomes in toxicological ICU? Acta Biomed. 2015; 86(1):63-8. http://www.mattioli1885journals.com/index.php/actabiomedica/article/download/3804/3155
Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA. 1995; 274(12):968-74. [DOI:10.1001/jama.1995.03530120060042] [PMID]
Lever A, Mackenzie I. Sepsis: Definition, epidemiology, and diagnosis. BMJ. 2007; 335(7625):879-83. [DOI:10.1136/bmj.39346.495880.AE] [PMID] [PMCID]
Lepak A, Andes D. Fungal sepsis: Optimizing antifungal therapy in the critical care setting. Crit Care Clin. 2011; 27(1):123-47. [DOI:10.1016/j.ccc.2010.11.001] [PMID]
Zilberberg MD, Shorr AF, Kollef MH. Secular trends in candidemia-related hospitalization in the United States, 2000-2005. Infect Control Hosp Epidemiol. 2008; 29(10):978-80. [DOI:10.1086/591033] [PMID]
Jain S. Epidemiology of viral Pneumonia. Clin Chest Med. 2017; 38(1):1-9. [DOI:10.1016/j.ccm.2016.11.012] [PMID] [PMCID]
Hall KK, Lyman JA. Updated review of blood culture contamination. Clin Microbiol Rev. 2006; 19(4):788-802. [DOI:10.1128/CMR.00062-05] [PMID] [PMCID]
Talaie H, Pajouhmand A, Abdollahi M, Panahandeh R, Emami H, Hajinasrolah S, et al. Rhabdomyolysis among acute human poisoning cases. Hum Exp Toxicol. 2007; 26(7):557-61. [DOI:10.1177/0960327107078667] [PMID]
Sivilotti MLA. Hematologic principles. In: Hoffman RS, Howland MA, Lewin NA, Nelson LS, Goldfrank LR, (editor). Goldfrank’s Toxicologic Emergencies, 10th Edition. New York: McGraw-Hill Education; 2014. https://accesspharmacy.mhmedical.com/Content.aspx?bookId=1163§ionId=65091652
Arabestani MR, Rastiany S, Kazemi S, Mousavi SM. Conventional, molecular methods and biomarkers molecules in detection of septicemia. Adv Biomed Res. 2015; 4:120.[DOI:10.4103/2277-9175.158027] [PMID] [PMCID]
Reier-Nilsen T, Farstad T, Nakstad B, Lauvrak V, Steinbakk M. Comparison of broad range 16S rDNA PCR and conventional blood culture for diagnosis of sepsis in the newborn: A case control study. BMC Pediatr. 2009; 9:5. [DOI:10.1186/1471-2431-9-5] [PMID] [PMCID]
Al-Zahrani AKh, Ghonaim MM, Hussein YM, Eed EM, Khalifa AS, Dorgham LS. Evaluation of recent methods versus conventional methods for diagnosis of early-onset neonatal sepsis. J Infect Dev Ctries. 2015; 9(4):388-93. [DOI:10.3855/jidc.5950] [PMID]
Makristathis A, Harrison N, Ratzinger F, Kussmann M, Selitsch B, Forstner C, et al. Substantial diagnostic impact of blood culture independent molecular methods in bloodstream infections: Superior performance of PCR/ESI-MS. Sci Rep. 2018; 8(1):16024. [DOI:10.1038/s41598-018-34298-7] [PMID] [PMCID]
Korber F, Zeller I, Grünstäudl M, Willinger B, Apfalter P, Hirschl AM, et al. SeptiFast versus blood culture in clinical routine - A report on 3 years experience. Wien Klin Wochenschr. 2017; 129(11-12):427-34. [DOI:10.1007/s00508-017-1181-3] [PMID] [PMCID]
Dinç F, Akalin H, Özakin C, Sinirtaş M, Kebabçi N, Işçimen R, et al. Comparison of blood culture and multiplex real-time PCR for the diagnosis of nosocomial sepsis. Minerva Anestesiol. 2016; 82(3):301-9. [PMID]
Erfantalab P, Soltaninejad K, Shadnia S, Zamani N, Hassanian-Moghaddam H, Mahdavinejad A, et al. Trend of blood lactate level in acute aluminum phosphide poisoning. World J Emerg Med. 2017; 8(2):116-20. [DOI:10.5847/wjem.j.1920-8642.2017.02.006] [PMID] [PMCID]
Zosel A, Egelhoff E, Heard K. Severe lactic acidosis after an iatrogenic propylene glycol overdose. Pharmacotherapy. 2010; 30(2):219-23. [DOI:10.1592/phco.30.2.219] [PMID] [PMCID]
Kruse JA. Methanol poisoning. Intensive Care Med. 1992; 18(7):391-7. [DOI:10.1007/BF01694340] [PMID]
Martín S, Pérez A, Aldecoa C. Sepsis and immunosenescence in the elderly patient: A review. Front Med (Lausanne). 2017; 28(4):20. [DOI:10.3389/fmed.2017.00020] [PMID]
Woźnica EA, Inglot M, Woźnica RK, Łysenko L. Liver dysfunction in sepsis. Adv Clin Exp Med. 2018; 27(4):547-51. [DOI:10.17219/acem/68363] [PMID]
Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis occurrence in acutely ill patients investigators. sepsis in European intensive care units: Results of the SOAP study. Crit Care Med. 2006; 34(2):344-53. [DOI:10.1097/01.CCM.0000194725.48928.3A] [PMID]
Bassetti S, Battegay M. Staphylococcus aureus infections in injection drug users: Risk factors and prevention strategies. Infection. 2004; 32(3):163-9. [DOI:10.1007/s15010-004-3106-0] [PMID]
Talaie H, Kamalbeik S, Mahdavinejad A, Pajoumand A, Bahreini Moghaddam SA. Health care practice, S. Aureus problem in Toxicological ICU, Loghman Hakim Hospital, Tehran-Iran. Iran J Clin Infect Dis. 2011; 6(Suppl):6-12. https://sites.kowsarpub.com/archcid/articles/78622.html
- Abstract Viewed: 174 times
- pdf Downloaded: 130 times